§ Funding Round
Series C funding round for ALX Oncology raising $110M in February 2020
Series C funding round for ALX Oncology raising $110M in February 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | carol gallagher | |
| Organization | — | |
| Organization | — | |
Vivo CapitalLEAD | Organization | — |
BVF Partners | — | — |
| Organization | — | |
| Organization | — | |
HBM Healthcare Investments | — | — |
Janus Henderson Investors | — | — |
| Organization | — | |
Logos Capital | — | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$146M
Top Valuation
-
ALX Oncology raised $110M in a Series C round.
The round was announced on 02/01/20.
The round was led by Vivo Capital.
